These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13735870)

  • 41. Syntheses and properties of selected derivatives of pyrimido[5,4-e]-1,3-thiazine and pyrimido[4,5-d]pyrimidine.
    Malinka W; Zawisza T; Zajac HE
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):487-97. PubMed ID: 2517913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of pyrimido[5,4-d]pyrimidine derivatives as peroxyoxalate chemiluminescence reagents using a flow injection system.
    Nakashima K; Maki K; Akiyama S; Imai K
    Biomed Chromatogr; 1990 May; 4(3):105-7. PubMed ID: 2383690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical applications of the fluorinated pyrimidines.
    ELLISON RR
    Med Clin North Am; 1961 May; 45():677-88. PubMed ID: 13726514
    [No Abstract]   [Full Text] [Related]  

  • 45. Characteristic cardiovascular effects of RA642, a pyrimido-pyrimidine derivative, in anesthetized dogs.
    Koyama S
    J Pharmacol Exp Ther; 1985 May; 233(2):480-4. PubMed ID: 3999030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [CHANGES IN THE LIPEMIC PICTURE AFTER THE INTRAVENOUS INJECTION OF PYRIMIDO PYRIMIDINE DERIVATES].
    DOMINGUEZLOPEZ J; FERNANDEZGARCIA JJ; PEREALOPEZ A; TALLONCANTERO R
    Rev Clin Esp; 1965 Jan; 96():37-41. PubMed ID: 14294603
    [No Abstract]   [Full Text] [Related]  

  • 47. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New heterocyclic structures. thiazolo[3,2-a][1,2,5] thiadiazolo[3,4-d]pyrimidine and [1,2,5]thiadiazolo[3',4':4,5] pyrimido[2,1-b][1,3]thiazine. biological assays.
    Rinaldi M; Pecorari P; Cermelli C; Malagoli M
    Farmaco; 1993 Mar; 48(3):427-33. PubMed ID: 8323673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Some preliminary clinical observations on the use of a new coronary dilator (RA-8) in syndromes of coronary insufficiency].
    COVA N; BREGANI P
    Minerva Cardioangiol; 1960 Sep; 8():431-6. PubMed ID: 13696065
    [No Abstract]   [Full Text] [Related]  

  • 50. Study of platelet aggregation in vivo: IV Effect of pyrimido-pyrimidine derivatives.
    Ambrus JL; Ambrus CM; Gastpar H; Thurber L; Miller R; Fretwell B; Lane KP
    J Med; 1977; 8(5):287-94. PubMed ID: 412904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and QSAR studies of pyrimido[4,5-d]pyrimidine-2,5-dione derivatives as potential antimicrobial agents.
    Sharma P; Rane N; Gurram VK
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4185-90. PubMed ID: 15261267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Present status of anticancer chemotherapy. III. The pyrimidines, N-desacetylthiocolchicine].
    RAVINA A; ELOY P
    Presse Med (1893); 1961 Mar; 69():587-90. PubMed ID: 13739897
    [No Abstract]   [Full Text] [Related]  

  • 53. The effects of 2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-D)pyrimidine (RA233) on the coronary circulation of the acutely transplanted dog heart: comparison with dipyridamole and adenosine.
    Paoloni HJ; Wilcken DE
    J Pharmacol Exp Ther; 1972 Oct; 183(1):137-45. PubMed ID: 4562619
    [No Abstract]   [Full Text] [Related]  

  • 54. [Results obtained with DG 428 in clinical cancerology].
    IZARN P; EMBERGER JM; GARY-BOBO J
    Montp Med; 1960 Nov; 58():156-64. PubMed ID: 13718404
    [No Abstract]   [Full Text] [Related]  

  • 55. Hemorrheologic effects of pyrimido-pyrimidine derivatives.
    Ambrus JL; Stadler I; Kulaylat M; Koreshi A; Akhtar S
    J Med; 1996; 27(1-2):21-32. PubMed ID: 8863175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.
    Romeo G; Materia L; Marucci G; Modica M; Pittalà V; Salerno L; Siracusa MA; Buccioni M; Angeli P; Minneman KP
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6200-3. PubMed ID: 17027264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pyrimido-pyrimidine derivative RA-642: a potent inhibitor of ferrous-induced lipid peroxidation in cell membranes.
    Bellido I; de la Cruz JP; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991; 13(6):371-5. PubMed ID: 1881198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
    Bacelar AH; Carvalho MA; Proença MF
    Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
    El-Sayed Ali T
    Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.